Dickkopf proteins in pathological inflammatory diseases

©2021 Society for Leukocyte Biology..

The human body encounters various challenges. Tissue repair and regeneration processes are augmented after tissue injury to reinstate tissue homeostasis. The Wnt pathway plays a crucial role in tissue repair since it induces target genes required for cell proliferation and differentiation. Since tissue injury causes inflammatory immune responses, it has become increasingly clear that the Wnt ligands can function as immunomodulators while critical for tissue homeostasis. The Wnt pathway and Wnt ligands have been studied extensively in cancer biology and developmental biology. While the Wnt ligands are being studied actively, how the Wnt antagonists and their regulatory mechanisms can modulate immune responses during chronic pathological inflammation remain elusive. This review summarizes DKK family proteins as immunomodulators, aiming to provide an overarching picture for tissue injury and repair. To this end, we first review the Wnt pathway components and DKK family proteins. Next, we will review DKK family proteins (DKK1, 2, and 3) as a new class of immunomodulatory protein in cancer and other chronic inflammatory diseases. Taken together, DKK family proteins and their immunomodulatory functions in chronic inflammatory disorders provide novel insights to understand immune diseases and make them attractive molecular targets for therapeutic intervention.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:111

Enthalten in:

Journal of leukocyte biology - 111(2022), 4 vom: 27. Apr., Seite 893-901

Sprache:

Englisch

Beteiligte Personen:

Park, Min Hee [VerfasserIn]
Shin, Jae Hun [VerfasserIn]
Bothwell, Alfred L M [VerfasserIn]
Chae, Wook-Jin [VerfasserIn]

Links:

Volltext

Themen:

Antagonist
Cancer
Immunologic Factors
Immunology
Intercellular Signaling Peptides and Proteins
Journal Article
Ligands
Research Support, Non-U.S. Gov't
Review
Wnt

Anmerkungen:

Date Completed 10.05.2022

Date Revised 02.04.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/JLB.3RI0721-385R

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM334266068